Kirin Holdings Reports 45% Jump in Q3 Profit
Kirin Holdings reported a substantial 45.0% year-over-year increase in net profit for the third quarter of fiscal year 2026, reaching ¥171.211 billion, driven by gains across its diverse business portfolio. This follows a 5.4% increase in revenue to ¥1.851563 trillion, signaling robust growth momentum for the Japanese beverage and pharmaceutical conglomerate.
The surge in profitability was underpinned by an 18.0% jump in business profit, reaching ¥201.183 billion, and a significant 34.4% rise in profit before taxes to ¥224.861 billion. These increases demonstrate an improved operational performance and effective cost management. Kirin’s full-year forecast projects revenue of ¥2.3 trillion, representing a 9.7% increase, and operating profit of ¥230 billion, up 9.7% compared to the previous year, indicating confidence in sustained growth.
The company’s performance is segmented across four key areas: beverages, alcohol, pharmaceuticals, and health science. While detailed segment-specific data is provided in the filing, the overall trend demonstrates broad-based strength. The company recently completed the sale of its Four Roses Distillery, LLC subsidiary, recognizing a gain of ¥29.033 billion on the transaction. However, a potential additional payment of approximately ¥8 billion exists contingent on future sales targets, highlighting ongoing financial considerations related to the divestiture.
Despite these positive results, Kirin Holdings is currently facing an antitrust investigation by the Japan Fair Trade Commission regarding suspected violations. While the financial impact remains unclear, the company has pledged full cooperation with the investigation. This investigation, coupled with a recent data breach at its FANCL subsidiary, represents ongoing risks that could influence future performance, although management has not yet quantified the financial consequences of either event. The company’s commitment to transparency and proactive risk management, as evidenced by its group risk and compliance committee, will be crucial in navigating these challenges.